Literature DB >> 8672742

Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.

H Kanagawa1, S Mima, H Kouyama, K Gotoh, T Uchida, K Okuda.   

Abstract

Although less common than oesophageal varices in portal hypertension, gastric fundal varices carry a higher mortality rate when they rupture. They are less amenable to sclerotherapy. We have developed a minimally invasive balloon-occluded retrograde transverse obliteration (B-RTO) procedure to treat gastric fundal varices. B-RTO involves inserting a balloon catheter into an outflow shunt (gastric-renal or gastric-vena caval inferior) via the femoral or internal jugular vein. Blood flow is then blocked by inflating the balloon, and 5% ethanolamine oleate iopamidol is injected in a retrograde manner. The embolized gastric varix subsequently disappears. B-RTO was performed in 32 patients with gastric varices. Follow-up endoscopies were performed at intervals of 2-4 months for an average observation period of 14 months. Eradication of the varices has been confirmed in 31 of 32 patients. No recurrence occurred in any patients in the follow-up period. There were no significant changes in liver function after the procedure. We conclude that B-RTO is a safe and effective procedure for the treatment of gastric fundal varices.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8672742     DOI: 10.1111/j.1440-1746.1996.tb00010.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  128 in total

1.  UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology.

Authors:  R Jalan; P C Hayes
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Role of multi-detector row CT angiography in the management of gastric fundal varices.

Authors:  A Matsumoto; Y Sugano; M Yasuda; K Takimoto
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

3.  Balloon-occluded retrograde transvenous obliteration for gastric varices via the intercostal vein.

Authors:  Hiroki Minamiguchi; Nobuyuki Kawai; Morio Sato; Akira Ikoma; Munehisa Sawa; Tetsuo Sonomura; Shinya Sahara; Kouhei Nakata; Isao Takasaka; Motoki Nakai
Journal:  World J Radiol       Date:  2012-03-28

4.  Balloon retrograde transvenous occlusion of fundic varix.

Authors:  Sanjeev Kumar Thakur; Siba Sankar Dalai
Journal:  Indian J Gastroenterol       Date:  2010-05-05

Review 5.  Management of rectal varices in portal hypertension.

Authors:  Kawtar Al Khalloufi; Adeyinka O Laiyemo
Journal:  World J Hepatol       Date:  2015-12-28

6.  Customization of laparoscopic gastric devascularization and splenectomy for gastric varices based on CT vascular anatomy.

Authors:  Hirofumi Kawanaka; Tomohiko Akahoshi; Yoshihiro Nagao; Nao Kinjo; Daisuke Yoshida; Yoshihiro Matsumoto; Norifumi Harimoto; Shinji Itoh; Tomoharu Yoshizumi; Yoshihiko Maehara
Journal:  Surg Endosc       Date:  2017-06-21       Impact factor: 4.584

7.  Inflammatory tumor in pancreas: a novel complication after endoscopic injection of cyanoacrylate for gastric fundal varices.

Authors:  Akio Matsumoto; Kengo Takimoto; Yuuki Yamauchi; Masashi Kuchide; Hideto Inokuchi
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

8.  A case of spontaneous splenorenal shunt associated with splenic artery aneurysm.

Authors:  Shogo Hayashi; Shuang-Qin Yi; Munekazu Naito; Hayato Terayama; Sichen Buhe; Yoichi Nakamura; Takayoshi Miyaki; Masahiro Itoh
Journal:  Surg Radiol Anat       Date:  2006-04-27       Impact factor: 1.246

Review 9.  Balloon-occluded retrograde transvenous obliteration for portal hypertension.

Authors:  Shozo Hirota; Kaoru Kobayashi; Hiroaki Maeda; Satoshi Yamamoto; Norio Nakao
Journal:  Radiat Med       Date:  2006-05

10.  Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.

Authors:  Tsuyoshi Ishikawa; Shogo Shiratsuki; Takashi Matsuda; Takuya Iwamoto; Taro Takami; Koichi Uchida; Shuji Terai; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2013-10-05       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.